Greene Kathleen
Connecticut Vascular Institute, Hartford 06106, USA.
J Vasc Nurs. 2002 Dec;20(4):117-22; quiz 123-4. doi: 10.1067/mvn.2002.129998.
This study compares duplex-guided thrombin injection (DGTI) with duplex-guided compression (DGC) for the treatment of iatrogenic pseudoaneurysms. A nonrandomized prospective study, approved by the institutional review board, was performed to evaluate the success rate in DGTI versus DGC (with the use of historical data) in patients who arrive at the vascular surgery service for the treatment of iatrogenic pseudoaneurysm as identified by ultrasound examination. DGTI has been shown to have major advantages over DGC, such as improved patient and operator acceptance, shorter pseudoaneurysm thrombosis times, broader patient applications, and higher success rate.
本研究比较了双重超声引导下注射凝血酶（DGTI）与双重超声引导下压迫（DGC）治疗医源性假性动脉瘤的效果。我们开展了一项经机构审查委员会批准的非随机前瞻性研究，以评估在血管外科就诊、经超声检查确诊为医源性假性动脉瘤的患者中，DGTI与DGC（采用历史数据）的成功率。结果表明，DGTI相对于DGC具有诸多主要优势，如患者和术者接受度更高、假性动脉瘤血栓形成时间更短、适用患者范围更广以及成功率更高。
